Compare Stocks → Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:IGXNASDAQ:PMNNYSEARCA:VRP Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIGXIntelGenx TechnologiesC$0.58+1.8%C$0.58C$0.17▼C$0.85C$87.32MN/A56,279 shs11,848 shsPMNProMIS Neurosciences$1.96-1.5%$2.05$0.95▼$8.95$37.16M0.6740,940 shs29,627 shsVRPInvesco Variable Rate Preferred ETF$23.46+0.2%$23.62$21.36▼$23.87$1.60B0.23335,564 shs320,485 shs10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIGXIntelGenx Technologies0.00%0.00%0.00%0.00%0.00%PMNProMIS Neurosciences-8.29%-20.08%+4.19%-22.87%-60.20%VRPInvesco Variable Rate Preferred ETF-0.13%-1.35%-1.27%+0.82%+4.79%Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIGXIntelGenx TechnologiesN/AN/AN/AN/AN/AN/AN/AN/APMNProMIS Neurosciences2.1557 of 5 stars3.54.00.00.01.11.70.6VRPInvesco Variable Rate Preferred ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIGXIntelGenx TechnologiesN/AN/AN/AN/APMNProMIS Neurosciences3.00Buy$8.00308.16% UpsideVRPInvesco Variable Rate Preferred ETF0.00N/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIGXIntelGenx TechnologiesC$1.75M49.95C$0.08 per share7.16C$0.05 per share12.89PMNProMIS Neurosciences$10K3,716.16N/AN/A$0.20 per share9.80VRPInvesco Variable Rate Preferred ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIGXIntelGenx TechnologiesN/A-C$0.08N/A∞N/AN/AN/AN/AN/APMNProMIS Neurosciences-$13.21M-$1.13N/AN/AN/AN/AN/A-141.23%5/20/2024 (Estimated)VRPInvesco Variable Rate Preferred ETFN/AN/A0.00∞N/AN/AN/AN/AN/ALatest VRP, PMN, TILS, and IGX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/1/2024Q4 2023PMNProMIS NeurosciencesN/A-$0.09-$0.09-$0.09N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIGXIntelGenx TechnologiesN/AN/AN/AN/AN/APMNProMIS NeurosciencesN/AN/AN/AN/AN/AVRPInvesco Variable Rate Preferred ETF$1.225.20%N/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIGXIntelGenx Technologies164.622.772.69PMNProMIS NeurosciencesN/A1.461.46VRPInvesco Variable Rate Preferred ETFN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipIGXIntelGenx TechnologiesN/APMNProMIS Neurosciences50.13%VRPInvesco Variable Rate Preferred ETFN/AInsider OwnershipCompanyInsider OwnershipIGXIntelGenx TechnologiesN/APMNProMIS Neurosciences10.30%VRPInvesco Variable Rate Preferred ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableIGXIntelGenx Technologies48150.55 millionN/ANot OptionablePMNProMIS Neurosciences618.96 million17.01 millionNot OptionableVRPInvesco Variable Rate Preferred ETFN/A68.10 millionN/ANot OptionableVRP, PMN, TILS, and IGX HeadlinesSourceHeadlineInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1064msn.com - March 19 at 8:10 AMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1020msn.com - February 20 at 7:14 AMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1667msn.com - December 18 at 1:57 PMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1668msn.com - November 22 at 8:34 AMNPFD: Expensive Fund With Hidden Fixed-Rate Exposuremsn.com - November 1 at 11:29 PMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1052seekingalpha.com - September 18 at 10:03 AMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1231msn.com - July 24 at 3:01 PMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1213msn.com - June 20 at 8:41 PMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1157seekingalpha.com - May 22 at 7:42 PMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1136msn.com - April 24 at 3:33 PMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1105msn.com - February 20 at 12:36 PMInvesco Variable Rate Preferred (VRP) Shares Cross Above 200 DMAnasdaq.com - January 10 at 7:50 PMInvesco Financial Preferred ETF (ARCA:PGF), Quotes and News Summarybenzinga.com - January 5 at 7:59 AMInvesco Variable Rate Investment Grade ETF declares monthly distribution of $0.1234msn.com - December 20 at 6:33 PMInvesco Preferred ETF declares monthly distribution of $0.0613msn.com - December 20 at 1:33 PMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1021msn.com - December 20 at 1:33 PMVRIG Invesco Actively Managed Exchange-Traded Fund Trust - Invesco Variable Rate Investment Grade ETFseekingalpha.com - October 1 at 2:43 PMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.0896seekingalpha.com - September 21 at 10:25 PMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.1094seekingalpha.com - July 20 at 12:02 AMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.0979seekingalpha.com - May 23 at 4:26 PMShares of VRP Now Oversoldnasdaq.com - May 2 at 10:31 PMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.0975seekingalpha.com - April 18 at 5:58 PMThe Right Way to Consider Preferred Stocks as Rates Risenasdaq.com - March 28 at 6:07 PMInvesco Variable Rate Preferred ETF declares monthly distribution of $0.0968seekingalpha.com - March 21 at 12:01 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsIntelGenx TechnologiesCVE:IGXIntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.ProMIS NeurosciencesNASDAQ:PMNProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.Invesco Variable Rate Preferred ETFNYSEARCA:VRPThe Invesco Variable Rate Preferred ETF (VRP) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund tracks a market-value-weighted index of variable- and floating-rate preferred stocks. VRP was launched on May 1, 2014 and is managed by Invesco. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.